Abasi Ene-Obong

Dr. Abasi Ene-Obong is the founder and CEO of 54gene, a health technology company advancing the state of healthcare through large scale discovery and translational research, advanced molecular diagnostics, and clinical programs for the benefit of Africans and the global population. Born in Nigeria, Abasi has extensive experience operating in the US, UK and Nigerian healthcare industries. Prior to 54gene, Abasi worked with leading healthcare organizations, including Fortune 100 pharmaceutical companies, academic and research institutions, and governments as a management consultant with PwC and IQVIA (formerly QuintilesIMS). Previously, Abasi worked as a cancer researcher and published a seminal paper on pancreatic cancer immunology in the journal, Gastroenterology. Abasi holds a Ph.D. in Cancer Biology from the University of London, a masters in human molecular genetics from the Imperial College London and a masters in business management from the Claremont Colleges, California.